Symphony Capital Overview
- Investor Type
-
PE/Buyout
- Status
-
Inactive
- Investments
-
10
- Portfolio
-
1
- Exits
-
7
Symphony Capital General Information
Description
Symphony Capital was a private equity firm dedicated to invest in the bio pharmaceutical companies. The firm was founded in 2002 and was headquartered in New York, New York
Contact Information
Website
www.symphonycapital.com
Year Founded
2002
Investor Status
Out of Business
Primary Investor Type
PE/Buyout
Primary Office
- 485 Madison Avenue
- 7th Floor
- New York, NY 10022
- United States
Symphony Capital Investments (10)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| The Network Control Group | 09-May-2022 | 0000 00000 | 00.000 | Electronic Equipment and Instruments | Generating Revenue | |
| The Network Control Group | 28-Aug-2019 | 0000 00000 | 00000 | Electronic Equipment and Instruments | Generating Revenue | |
| Mateon Therapeutics | 09-Dec-2008 | 0000 | 0000 | Drug Discovery | Generating Revenue | 0000 000000 00 |
| DLF Assets | 04-Nov-2008 | 0000000000 | Buildings and Property | Generating Revenue | ||
| Symphony ViDA | 30-Sep-2008 | PE Growth/Expansion | 0000 | Biotechnology | Clinical Trials - Phase 2 | 0000 000000 00 |
Symphony Capital Exits (7)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Symphony Icon | 02-Aug-2010 | 000000000000000000 | 0000 |
| Symphony Dynamo | 04-Jan-2010 | 000000000000000000 | 000.00 |
| DLF Assets | 11-Dec-2009 | 000000000000000000 | |
| Symphony Allegro | 26-Aug-2009 | 000000000000000000 | 000.00 |
| Symphony ViDA | 20-Jul-2009 | Merger/Acquisition | 00.00 |
Symphony Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Symphony Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
